Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential

TG Martin, MA Juarros, LA Leinwand - Nature Reviews Cardiology, 2023 - nature.com
Left ventricular hypertrophy is a leading risk factor for cardiovascular morbidity and mortality.
Although reverse ventricular remodelling was long thought to be irreversible, evidence from …

[HTML][HTML] Mitochondria and cardiovascular diseases—from pathophysiology to treatment

G Siasos, V Tsigkou, M Kosmopoulos… - Annals of …, 2018 - ncbi.nlm.nih.gov
Mitochondria are the source of cellular energy production and are present in different types
of cells. However, their function is especially important for the heart due to the high demands …

Influence of physical activity on hypertension and cardiac structure and function

SM Hegde, SD Solomon - Current hypertension reports, 2015 - Springer
The global burden of hypertension is rising and accounts for substantial morbidity and
mortality. Lifestyle factors such as diet and physical inactivity contribute to this burden …

The fibrosis-cell death axis in heart failure

A Piek, RA De Boer, HHW Silljé - Heart failure reviews, 2016 - Springer
Cardiac stress can induce morphological, structural and functional changes of the heart,
referred to as cardiac remodeling. Myocardial infarction or sustained overload as a result of …

Physiological and pathological cardiac hypertrophy

I Shimizu, T Minamino - Journal of molecular and cellular cardiology, 2016 - Elsevier
The heart must continuously pump blood to supply the body with oxygen and nutrients. To
maintain the high energy consumption required by this role, the heart is equipped with …

Mechanisms for the transition from physiological to pathological cardiac hypertrophy

CJ Oldfield, TA Duhamel… - Canadian journal of …, 2020 - cdnsciencepub.com
The heart is capable of responding to stressful situations by increasing muscle mass, which
is broadly defined as cardiac hypertrophy. This phenomenon minimizes ventricular wall …

Signaling effectors underlying pathologic growth and remodeling of the heart

JH Van Berlo, M Maillet… - The Journal of clinical …, 2013 - Am Soc Clin Investig
Cardiovascular disease is the number one cause of mortality in the Western world. The heart
responds to many cardiopathological conditions with hypertrophic growth by enlarging …

miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart

BC Bernardo, JYY Ooi, RCY Lin… - Future medicinal …, 2015 - Taylor & Francis
miRNAs are small non-coding RNAs (ncRNAs), which regulate gene expression. Here, the
authors describe the contribution of miRNAs to cardiac biology and disease. They discuss …

Republished: Basic science behind the cardiovascular benefits of exercise

MG Wilson, GM Ellison, NT Cable - Postgraduate Medical …, 2015 - academic.oup.com
Cardiorespiratory fitness is a strong predictor of cardiovascular (CV) disease and all-cause
mortality, with increases in cardiorespiratory fitness associated with corresponding …

[HTML][HTML] miR-17-3p contributes to exercise-induced cardiac growth and protects against myocardial ischemia-reperfusion injury

J Shi, Y Bei, X Kong, X Liu, Z Lei, T Xu, H Wang… - Theranostics, 2017 - ncbi.nlm.nih.gov
Limited microRNAs (miRNAs, miRs) have been reported to be necessary for exercise-
induced cardiac growth and essential for protection against pathological cardiac …